These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25079212)

  • 1. Regulation of osteoclastogenesis by integrated signals from toll-like receptors.
    Krisher T; Bar-Shavit Z
    J Cell Biochem; 2014 Dec; 115(12):2146-54. PubMed ID: 25079212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
    Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
    J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides.
    Amcheslavsky A; Bar-Shavit Z
    J Cell Physiol; 2006 Apr; 207(1):244-50. PubMed ID: 16402377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide-induced osteoclastogenesis in Src homology 2-domain phosphatase-1-deficient viable motheaten mice.
    Hayashi S; Tsuneto M; Yamada T; Nose M; Yoshino M; Shultz LD; Yamazaki H
    Endocrinology; 2004 Jun; 145(6):2721-9. PubMed ID: 14988381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 9 ligand blocks osteoclast differentiation through induction of phosphatase.
    Amcheslavsky A; Bar-Shavit Z
    J Bone Miner Res; 2007 Aug; 22(8):1301-10. PubMed ID: 17488193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.
    Hayashi S; Yamada T; Tsuneto M; Yamane T; Takahashi M; Shultz LD; Yamazaki H
    J Immunol; 2003 Nov; 171(10):5130-9. PubMed ID: 14607912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via Toll-like receptor 9.
    Zou W; Amcheslavsky A; Bar-Shavit Z
    J Biol Chem; 2003 May; 278(19):16732-40. PubMed ID: 12611893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual modulation of osteoclast differentiation by lipopolysaccharide.
    Zou W; Bar-Shavit Z
    J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG oligonucleotides: novel regulators of osteoclast differentiation.
    Zou W; Schwartz H; Endres S; Hartmann G; Bar-Shavit Z
    FASEB J; 2002 Mar; 16(3):274-82. PubMed ID: 11874977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 9 regulates tumor necrosis factor-alpha expression by different mechanisms. Implications for osteoclastogenesis.
    Amcheslavsky A; Zou W; Bar-Shavit Z
    J Biol Chem; 2004 Dec; 279(52):54039-45. PubMed ID: 15485822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
    Arsenault RJ; Kogut MH; He H
    Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy of CpG oligodeoxynucleotide and double-stranded RNA (poly I:C) on nitric oxide induction in chicken peripheral blood monocytes.
    He H; Genovese KJ; Nisbet DJ; Kogut MH
    Mol Immunol; 2007 May; 44(12):3234-42. PubMed ID: 17339052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation by toll-like receptors inhibits osteoclast differentiation.
    Takami M; Kim N; Rho J; Choi Y
    J Immunol; 2002 Aug; 169(3):1516-23. PubMed ID: 12133979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
    Grcević D; Lukić IK; Kovacić N; Ivcević S; Katavić V; Marusić A
    Clin Exp Immunol; 2006 Oct; 146(1):146-58. PubMed ID: 16968409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling.
    AlQranei MS; Senbanjo LT; Aljohani H; Hamza T; Chellaiah MA
    BMC Immunol; 2021 Mar; 22(1):23. PubMed ID: 33765924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro.
    Gorny G; Shaw A; Oursler MJ
    Exp Cell Res; 2004 Mar; 294(1):149-58. PubMed ID: 14980510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG oligodeoxynucleotide and double-stranded RNA synergize to enhance nitric oxide production and mRNA expression of inducible nitric oxide synthase, pro-inflammatory cytokines and chemokines in chicken monocytes.
    He H; MacKinnon KM; Genovese KJ; Kogut MH
    Innate Immun; 2011 Apr; 17(2):137-44. PubMed ID: 20083501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity.
    Whitmore MM; DeVeer MJ; Edling A; Oates RK; Simons B; Lindner D; Williams BR
    Cancer Res; 2004 Aug; 64(16):5850-60. PubMed ID: 15313929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphatidylinositol 3-kinase-mediated production of interferon-beta is critical for the lipopolysaccharide inhibition of osteoclastogenesis.
    Lee Y; Huang H; Kim HJ; Park CK; Kim HH
    Life Sci; 2008 Aug; 83(9-10):369-76. PubMed ID: 18675826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.